Calviri
PrivateLast Round
Crowdfunding
Aug 21, 2024
Est. Valuation
$165.8M
Total Funding Raised
$13.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Calviri operates in Healthcare & Life Sciences and is based in Phoenix, Arizona. Its latest recorded funding round was a Seed round in April 2020.
Calviri is a biotechnology company developing a broad spectrum of vaccines and companion diagnostics to prevent and treat cancer in both canines and humans.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Calviri Comparables
Compare Calviri with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mercy BioAnalytics | 83% | |
| AOA Dx | 81% | |
| Adela | 81% |
For institutional investors. Book with your work email.
Calviri Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 21, 2024 | ||||
| Seed | Apr 2, 2020 | ||||
| Grant | Jan 3, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Calviri Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coefficient Giving | Grant |
| Open Philanthropy | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 86% MoM.
- Jul 23, 2024
Raised $1.2M in a crowdfunding round.
For institutional investors. Book with your work email.
Calviri Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Calviri's valuation, stock price, and market status.
Is Calviri a public or private company?
Calviri is a private company.
What is the current stock price of Calviri?
Calviri is a private company, so its shares have no public market price. Caplight tracks Calviri's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Calviri worth (valuation)?
Calviri's valuation is estimated at $165.8M based on funding round data.
Can I buy Calviri stock?
Calviri shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Calviri's last funding round?
Calviri's most recent funding round was Crowdfunding on August 21, 2024.
Who are the main investors in Calviri?
Key investors in Calviri include Open Philanthropy.
Will Calviri IPO soon?
No public IPO plans have been announced for Calviri.
How can I track Calviri secondary market activity?
Caplight tracks bids, offers, and trades in Calviri's shares on secondary markets.